Umbilical cord blood-derived dendritic cells loaded with BGC823 tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo

Central European Journal of Immunology

Volumn 39, Issue 2, 2014, Pages 142-151

  Guan, Shasha ^a   Li, Qianru ^a   Liu, Pingping ^a   Xuan, Xiaoyan ^a   Du, Ying ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Antitumor immunity; BGC823 cell line; Dendritic cells; Exosomes

Indexed keywords

DENDRITIC CELL DERIVED EXOSOME VACCINE; DENDRITIC CELL VACCINE; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BGC823 CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DRUG EFFECT; EXOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROSCOPY; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; TUMOR IMMUNITY; ULTRACENTRIFUGATION; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

EID: 84904468202     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2014.43713     Document Type: Article

References (17)

1. Tel J, van der Leun AM, Figdor CG, et al. (2012): Harnessing human plasmacytoid dendritic cells as professional APCs. Cancer Immunol Immunother 61: 1279-1288.
2. Palucka K, Banchereau J, Mellman I (2010): Designing vaccines based on biology of human dendritic cell subsets. Immunity 33: 464-478.
3. Boudreau JE, Bonehill A, Thielemans K, Wan Y (2011): Engineering dendritic cells to enhance cancer immunotherapy. Mol Ther 19: 841-853.
4. Cai Z, Zhang W, Yang F, et al. (2012): Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell Res 22: 607-610.
5. Viaud S, Terme M, Flament C (2009): Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Rα. PLoS One 4: e4942.
6. Wan S, Zhou Z, Duan B, Morel L (2008): Direct B cell stimulation by dendritic cells in a mouse model of lupus. Arthritis Rheum 58: 1741-1750. (Pubitemid 351847528)
7. Zitvogel L, Regnault A, Lozier A, et al. (1998): Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4: 594-600. (Pubitemid 28237359)
8. Cho JA, Lee YS, Kim SH, et al. (2009): MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. Cancer Lett 275: 256-265.
9. Matsuyoshi H, Senju S, Hirata S, et al. (2004): Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination. J Immunol 172: 776-786. (Pubitemid 38113733)
10. Gabrilovich DI, Ishida T, Nadaf S, et al. (1999): Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin Cancer Res 5: 2963-2970. (Pubitemid 29493976)
11. Villa CH, Dao T, Ahearn I, et al. (2011): Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens. ACS Nano 5: 5300-5311.
12. Palucka K, Banchereau J (2012): Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12: 265-277.
13. Van Nuffel AM, Benteyn D, Wilgenhof S, et al. (2012): Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients. Mol Ther 20: 1063-1074.
14. Barrio MM, Abes R, Colombo M, et al. (2012): Human macrophages and dendritic cells can equally present MART-1 antigen to CD8 + T cells after phagocytosis of gamma-irradiated melanoma cells. PLoS One 7: e40311.
15. Barrio MM, Abes R, Colombo M, et al. (2004): CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model. Immunology 112: 117-125.
16. Zhuang X, Xiang X, Grizzle W, et al. (2011): Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19: 1769-1779.
17. Zhuang X, Xiang X, Grizzle W, et al. (2012): Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology 136: 192-197.